Last Updated on July 1, 2026 by Dr. Bhagat
Journal profile·Updated June 2026
(Latest) Cancer Immunology Research Impact Factor 2025
Impact factor, quartile, citation metrics, and key facts for (Latest) Cancer Immunology Research Impact Factor 2025 — updated June 2026.
Cancer Immunology Research Impact Factor 2025 (Updated June 2026) | IF, Ranking, H-Index & Acceptance Rate
Keywords: Cancer Immunology Research Impact Factor, Cancer Immunology Research Impact Factor 2025, Cancer Immunology Research Journal Impact Factor, Impact Factor of Cancer Immunology Research, Cancer Immunology Research IF 2025, Cancer Immunology Research Journal Ranking
Last updated: June 25, 2026 — Cancer Immunology Research is a leading peer-reviewed academic journal. For 2025, Cancer Immunology Research Impact Factor is 7.9 according to the latest Journal Citation Reports (JCR) data, reaffirming its position as a top-tier Q1 publication.
Cancer Immunology Research publishes high-quality original research, reviews, and other scholarly articles. The journal is widely recognized in the scientific community and maintains rigorous peer review standards to ensure published research meets the highest academic criteria. With a global readership and strong citation metrics, Cancer Immunology Research serves as a key venue for researchers seeking to disseminate impactful findings.
Cancer Immunology Research Impact Factor at a Glance
| Metric | Value |
|---|---|
| 2025 Impact Factor (JCR) | 7.9 |
| CiteScore (Scopus) | 9.48 |
| SJR (Scimago Journal Rank) | 0.63 |
| H-Index | 150+ |
| JCR Quartile | Q1 |
| Publisher | Major Publisher |
| Acceptance Rate | 15-25% |
| Peer Review Time | 30-60 days (median) |
| APC (Article Processing Charge) | $3,000-5,000 USD |
| ISSN | 2326-6066 (Print); 2326-6074 (Online) |
What is Cancer Immunology Research Impact Factor in 2025?
Cancer Immunology Research Impact Factor 2025 is 7.9, as reported in the Journal Citation Reports (JCR) released by Clarivate in June 2026. This metric reflects the average number of citations received per peer-reviewed article published in Cancer Immunology Research during the preceding two years (2023-2024).
The Impact Factor is calculated by dividing the total number of citations in 2025 to Cancer Immunology Research articles published in 2023 and 2024 by the total number of citable items published in those same two years. This standardized methodology allows researchers to compare citation performance across journals.
Is Cancer Immunology Research Q1 Journal?
Yes, Cancer Immunology Research is a Q1 journal. It ranks in the first quartile of its JCR category, indicating higher citation impact than 75% of journals in its field.
Is Cancer Immunology Research SCI Indexed?
Yes, Cancer Immunology Research is SCI indexed. The journal is included in the Science Citation Index Expanded (SCIE), which is part of the Web of Science Core Collection.
Is Cancer Immunology Research SCIE Indexed?
Yes, Cancer Immunology Research is SCIE indexed. All original research articles and reviews published in Cancer Immunology Research are indexed and trackable via the Web of Science platform.
Cancer Immunology Research CiteScore
Cancer Immunology Research CiteScore is approximately 9.48 according to Scopus data. CiteScore measures average citations per document over a four-year window.
Cancer Immunology Research Quartile Ranking
Cancer Immunology Research is ranked Q1 in its JCR category. In Scopus/Scimago rankings, it also maintains Q1 status in its primary subject areas.
Cancer Immunology Research JCR Ranking
Cancer Immunology Research ranks among the top journals in its category with an Impact Factor of 7.9. This places it in the upper tier of publications in its field, attracting high-quality submissions from leading researchers worldwide.
Cancer Immunology Research Publisher
Cancer Immunology Research is published by Major Publisher. The journal maintains editorial independence and follows rigorous peer review standards.
Cancer Immunology Research ISSN
The ISSN for Cancer Immunology Research can be found on the official publisher website or the journal’s homepage. ISSN identifiers are used for cataloging and citation tracking across all major bibliographic databases.
Cancer Immunology Research Impact Factor Trend (2017-2025)
| Year | Impact Factor | Change |
|---|---|---|
| 2017 | 5.5 | — |
| 2018 | 6.0 | +0.5 |
| 2019 | 6.5 | +0.5 |
| 2020 | 7.7 | +1.2 |
| 2021 | 8.3 | +0.6 |
| 2022 | 7.3 | -1.0 |
| 2023 | 7.1 | -0.2 |
| 2024 | 7.5 | +0.4 |
| 2025 | 7.9 | +0.4 |
Analysis: Cancer Immunology Research Impact Factor has shown strong growth over the 9-year period, with the 2025 value of 7.9 representing its latest position in the JCR rankings.
Cancer Immunology Research vs Comparable Journals
| Journal | 2025 IF | Quartile | Index | Publisher |
|---|---|---|---|---|
| Nature | 56.1 | Q1 | SCIE | Major Publisher |
| Science | 47.3 | Q1 | SCIE | Major Publisher |
| Cell | 45.1 | Q1 | SCIE | Major Publisher |
Who Should Publish in Cancer Immunology Research?
Cancer Immunology Research is ideal for researchers who:
- Conduct high-quality, original research in the journal’s scope.
- Seek a prestigious Q1 journal with strong citation metrics.
- Value rigorous peer review and broad readership.
- Need a journal with established indexing in SCIE, Scopus, and other major databases.
Cancer Immunology Research Submission Tips
- Align with scope: Ensure your research fits the journal’s aims and scope.
- Follow guidelines: Adhere to manuscript formatting and reference style requirements.
- Prepare a compelling abstract: This is critical for attracting reviewers and readers.
- Consider open access: Evaluate whether the APC open access option is suitable for your work.
Cancer Immunology Research Acceptance Rate in Context
Cancer Immunology Research acceptance rate is approximately 15-25%, reflecting its selective peer review process. This ensures only high-quality research that meets the journal’s standards is published.
Cancer Immunology Research Review Time
| Stage | Typical Duration |
|---|---|
| Initial Editorial Assessment | 1-7 days |
| Peer Review (if sent out) | 2-6 weeks |
| Editorial Decision | 1-2 weeks after reviews |
| Revision Period (if required) | 1-3 months |
| Total Time to First Decision | 30-60 days |
Cancer Immunology Research Publication Fee (APC)
Cancer Immunology Research Article Processing Charge (APC) for open access is $3,000-5,000 USD. This fee applies to authors who choose immediate open access. Check the publisher’s website for the most current fee and any waiver policies.
Cancer Immunology Research Reference Style
Cancer Immunology Research uses a standard reference style. Authors should consult the journal’s official author guidelines for the exact formatting requirements, which typically follow either Vancouver or APA style depending on the publisher.
Cancer Immunology Research Indexed In
Cancer Immunology Research is indexed in major scientific databases, including:
- Web of Science — SCIE (Science Citation Index Expanded)
- Scopus
- PubMed / MEDLINE (if applicable)
- Google Scholar
- Directory of Open Access Journals (DOAJ) (for open access articles)
Cancer Immunology Research Editors
Cancer Immunology Research operates under the editorial leadership of an Editor-in-Chief and Editorial Board. The editorial team is committed to fair, rapid, and transparent peer review. See the journal’s official website for current editorial board information.
FAQ
1. What is the current Cancer Immunology Research Impact Factor?
The Cancer Immunology Research Impact Factor 2025 is 7.9 according to the latest JCR data released in June 2026.
2. Is Cancer Immunology Research a Q1 journal?
Yes, Cancer Immunology Research is ranked Q1 in its JCR category.
3. Is Cancer Immunology Research indexed in SCIE?
Yes, Cancer Immunology Research is fully indexed in SCIE (Science Citation Index Expanded).
4. What is the Cancer Immunology Research acceptance rate?
Cancer Immunology Research has an acceptance rate of approximately 15-25%.
5. How long does Cancer Immunology Research peer review take?
The median peer review time is approximately 30-60 days.
6. What is the Cancer Immunology Research APC (open access fee)?
The Cancer Immunology Research Article Processing Charge for open access is $3,000-5,000 USD.
7. Who publishes Cancer Immunology Research?
Cancer Immunology Research is published by Major Publisher.
8. Is Cancer Immunology Research open access?
Cancer Immunology Research operates a hybrid or fully open access model depending on the publisher’s policy.
9. What is the Cancer Immunology Research CiteScore?
Cancer Immunology Research CiteScore is approximately 9.48 based on Scopus data.
10. Does Cancer Immunology Research publish review articles?
Yes, Cancer Immunology Research publishes original research, reviews, and other article types depending on its scope.
11. Can international authors submit to Cancer Immunology Research?
Yes, Cancer Immunology Research welcomes submissions from researchers worldwide regardless of nationality.
12. What is the Cancer Immunology Research H-index?
Cancer Immunology Research has an H-index of 150+, indicating high cumulative citation impact.
13. When is the next Cancer Immunology Research Impact Factor announced?
JCR Impact Factors are typically released by Clarivate in June each year for the preceding year.
14. Is Cancer Immunology Research a predatory journal?
No, Cancer Immunology Research is a legitimate, peer-reviewed journal indexed in major databases including Web of Science and Scopus.
15. How does Cancer Immunology Research compare to similar journals?
With an Impact Factor of 7.9, Cancer Immunology Research ranks competitively within its category. See the comparison table above for detailed analysis.
Read More
Related Journal Impact Factors
- Nature Impact Factor 2025
- Science Impact Factor 2025
- Cell Impact Factor 2025
- Nature Communications Impact Factor
- Science Advances Impact Factor
- Nature Medicine Impact Factor
- JAMA Impact Factor
- NEJM Impact Factor
- The Lancet Impact Factor
- Cell Reports Impact Factor
- eLife Impact Factor
- PLOS ONE Impact Factor
- iScience Impact Factor
- Scientific Reports Impact Factor
- Journal of Biological Chemistry Impact Factor
External Resources
About This Data
This article was compiled and verified by the editorial team at ImpactFactorForJournal.com. All data is sourced from the Journal Citation Reports (JCR) 2026 edition (covering 2025 data), released by Clarivate Analytics in June 2026.
Methodology: Impact Factor values are calculated by dividing the number of citations in a given year to items published in the previous two years by the total number of citable items published in those two years.
E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness): This page is maintained by research information specialists with direct access to licensed JCR and Scopus databases. Data is cross-verified against official publisher statements and updated within 48 hours of new JCR releases.
Disclaimer: Journal Impact Factors are subject to change annually. While every effort is made to ensure accuracy, authors should verify the latest metrics directly with Clarivate or the journal publisher before making publication decisions.
At a glanceKey takeaways
- (Latest) Cancer Immunology Research Impact Factor 2025 holds a strong impact factor of 2025, placing it among notable journals in its category.
- It ranks in Q1, indicating it is in the top 25% of journals in its field.
- Always verify current metrics at the official source before submitting.
- Consider scope, audience fit, and turnaround time alongside impact factor when choosing a journal.
FAQPeople also ask
What is the impact factor of Cancer Immunology Research Impact Factor 2025?
What is the quartile ranking of Cancer Immunology Research Impact Factor 2025?
Who publishes Cancer Immunology Research Impact Factor 2025?
Can I submit my research to Cancer Immunology Research Impact Factor 2025?
SourcesReferences & further reading
Impact-factor figures on this page are drawn from Journal Citation Reports (Clarivate), 2025 release — the most recent Journal Impact Factor data, retrieved June 2026. Metrics change annually — always confirm time-sensitive values at the official source before relying on them.
